TYNDALL CAPITAL PARTNERS L P sold 1.3% of their position (10.93K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $30.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/11/2019ACC: 0000905718-19-000596
10% Owner
Since Jun 2019
-10.93K
Net shares
Net seller
$30.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.93K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−8.19K
Price / share
$2.83
Trade value
$23.20K
% of position
1.0%
7/9/2019
813.43K→805.25K
Common Stock
Indirect
Shares
−2.74K
Price / share
$2.81
Trade value
$7.70K
% of position
0.3%
7/10/2019
805.25K→802.51K
Total
Net shares
−10.93K
Net value
-$30.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/9/2019 | S · Sale | −8.19K | $2.83 | $23.20K | 1.0% | 813.43K | 805.25K |
| Common Stock Indirect | 7/10/2019 | S · Sale | −2.74K | $2.81 | $7.70K | 0.3% | 805.25K | 802.51K |
| Total | −10.93K | -$30.90K | ||||||
Derivative Transactions0
No derivative transactions reported